Immunotherapy Breakthroughs and Single-Cell Atlas Studies Reshape Liver Cancer Care in China
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
Researchers built a five-gene PANoptosis-based risk model and nomogram that predict survival, immune landscape, and treatment sensitivity in esophageal cancer ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
A sweeping new review maps how the epithelial guardian protein MUC1, and especially its MUC1-C signaling subunit, is hijacked by ...
Johns Hopkins researchers measured the metabolism of immune cells inside human head and neck tumors and found that exhausted T ...
Researchers engineered fratricide-resistant CD70-targeting natural killer cells that potently killed patient-derived glioblastoma cells in laboratory and animal models.
A new study shows that lipid nanoparticle-delivered CAR mRNA engineers both human T cells and macrophages against CD19-positive leukemia cells, ...
A new review argues that patient-derived glioblastoma organoids could finally provide a realistic platform for testing immunotherapies, including oncolytic herpes ...
Researchers engineered a cyanine photosensitizer with a benzophenone electron-pumping group and loaded it into a pH-responsive, hyaluronic acid-coated iron nanozyme ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine